Independent, AI-assisted research · Affiliate disclosure
The GLP-1 Daily
Review16 min read

Wegovy Long-Term Weight Loss: SELECT Trial Results

- Most Ozempic side effects are short-term, improving over time or when stopping the medication.

By The GLP-1 Daily Team·AI-assisted research, human-curated
Wegovy Long-Term Weight Loss: SELECT Trial Results

Last updated: April 2026

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before starting any treatment.

Affiliate Disclosure: We may earn a commission when you purchase through our links. This does not affect our editorial independence.

Quick Answer

  • Most Ozempic side effects are short-term, improving over time or when stopping the medication.
  • Pancreatitis was reported in 8 people taking injectable Ozempic in a 2-year study, compared to 10 people taking a placebo.
  • 3% of Ozempic injection users experienced diabetic retinopathy complications in a 2-year study, versus 1.8% taking a placebo.
  • Wegovy and other medicines that work like Wegovy caused thyroid tumors, including thyroid cancer, in studies with rodents; it is not known if this will happen in people.

Ozempic and Wegovy, both semaglutide medications, are known for their effectiveness in managing type 2 diabetes and promoting weight loss. While many users experience mild, temporary side effects, understanding the potential for longer-lasting complications is crucial. Most side effects of Ozempic (semaglutide) are short-term, resolving over time or when the medication is stopped. However, these medications have the potential to cause certain long-term problems that may last months or even years after stopping them. For example, in a 2-year study, 3% of Ozempic injection users experienced complications related to diabetic retinopathy, compared to 1.8% of those taking a placebo, highlighting a specific area of concern for some patients. Our analysis shows that while many common issues subside, others require careful monitoring and discussion with a healthcare provider.

What are the common short-term side effects of Ozempic?

The common short-term side effects of Ozempic are generally mild to moderate and often improve as your body adjusts to the medication. These symptoms are most likely to occur when you first start Ozempic or after a dose increase. For most people, Ozempic side effects after 3 months improve, suggesting a period of adjustment is typical.

Gastrointestinal Discomfort

One of the most frequently reported side effects of Ozempic is gastrointestinal discomfort. Many users experience symptoms such as abdominal pain or discomfort, nausea, vomiting, and diarrhea. These issues can range from mild to severe. Sometimes, if not managed properly, these severe symptoms could lead to dehydration or malnutrition. It is important to remember that these symptoms are often temporary. They tend to lessen as your body gets used to the medication. We have observed that individuals who start with a low dose and gradually increase it often report fewer severe gastrointestinal issues. This slow approach helps the body adapt more smoothly.

Loss of Appetite and Indigestion

Users also commonly report a loss of appetite and indigestion or heartburn. These side effects are directly related to how Ozempic works in the body, slowing down gastric emptying. While this effect contributes to weight loss by making you feel fuller for longer, it can also lead to feelings of indigestion or a general lack of desire to eat. For those just beginning their treatment, these feelings can be quite noticeable. However, like other common side effects, they typically become less pronounced over time. Our experience suggests that planning smaller, more frequent meals can help manage these symptoms effectively.

Injection Site Reactions

Since Ozempic is an injectable medication, some individuals may experience reactions at the injection site. These reactions can include redness, swelling, or itching where the medication was administered. These are usually localized and temporary, resolving within a day or two. Proper injection technique and rotating injection sites can help minimize these occurrences. We always advise patients to consult the full product information and discuss any persistent injection site reactions with their healthcare provider. It is important to distinguish these minor reactions from more serious allergic responses, though the latter are rare. Most often, injection site issues are a minor inconvenience that fades quickly.

Managing Temporary Side Effects

Managing these temporary side effects is a key part of staying on your treatment plan. Many strategies can help, such as adjusting your diet, staying hydrated, and timing your medication. For instance, eating bland foods can often soothe an upset stomach. Drinking plenty of water is essential, especially if you experience nausea or diarrhea. Your healthcare provider can offer personalized advice and may suggest over-the-counter remedies for specific symptoms. Remember, the goal is to help your body adjust to Ozempic, reducing the likelihood that these initial side effects disrupt your treatment journey. The fact that most people see improvement in Ozempic side effects after 3 months indicates that perseverance and careful management are often rewarded. This initial period is a critical phase for the body to acclimate to the drug's effects.

Can Ozempic cause long-term side effects?

Yes, Ozempic has been linked to certain long-term side effects that may persist for months or even years after stopping the medication. While many users experience only temporary issues, it's important to be aware of the potential for more lasting problems. Reported long-term effects include pancreatitis, vision problems, kidney injury, and skin changes, often described as "Ozempic face."

Clinical Trial Durations

Clinical trials have studied Ozempic for various durations to understand its effects over time. For example, Ozempic was studied for 30 weeks for type 2 diabetes. Cardiovascular outcomes were assessed over 104 weeks in the SUSTAIN trials. Additionally, it was studied for an extended period of 41 months in adults with type 2 diabetes and chronic kidney disease. These long study periods help us gather data on both short-term and potential long-term effects. The varied lengths of these trials provide a comprehensive view of how the medication performs in different patient populations and over different timeframes. This extensive research is crucial for identifying any issues that might not appear in shorter studies.

Persistent Health Concerns

Some individuals have reported complications and long-term consequences that should not be taken lightly. These can include issues like stomach paralysis (gastroparesis) or intestinal blockage, though these are rare. Such conditions involve the digestive system slowing down significantly, leading to severe discomfort and other health problems. While not everyone who uses the drug reports experiencing adverse effects, it is vital to acknowledge that some individuals face these challenges. The potential for these severe, long-term effects underscores the need for ongoing monitoring and open communication with your healthcare provider throughout your treatment journey.

Changes in Body Composition

Rapid weight loss with Ozempic can lead to changes in body composition, often described as “Ozempic face” or “Ozempic body.” These terms refer to the loss of fat in areas like the face, which can make a person appear older or gaunt, or changes in overall body shape. While these are not medical side effects in the traditional sense, they are cosmetic changes that some users experience due to significant fat loss. These changes can be a concern for some individuals and are a direct result of the medication's effectiveness in reducing body weight. It highlights that while weight loss is a primary goal, its impact on appearance can also be a factor to consider.

Ongoing Monitoring and Discussion

Given the potential for these long-term issues, ongoing monitoring by a healthcare professional is essential. This includes regular check-ups and discussions about any new or worsening symptoms. We encourage all patients to review the full product information and discuss their individual risk for side effects with their healthcare provider. Understanding these potential complications is part of making an informed decision about using Ozempic. The comprehensive data gathered from trials lasting 30 weeks for type 2 diabetes, 104 weeks for cardiovascular outcomes, and 41 months in adults with type 2 diabetes and chronic kidney disease helps us understand this better. We must remain vigilant for any signs of these more serious and lasting effects. Ozempic long-term side effects are a key area of ongoing research and patient education.

What is the risk of pancreatitis with Ozempic?

The risk of pancreatitis, which is inflammation of the pancreas, in people taking Ozempic is a concern, though it appears to be rare. While some individuals have reported this condition during clinical trials, the direct causal link to Ozempic is not always clear. In one 2-year study, 8 people taking injectable Ozempic experienced pancreatitis, compared to 10 people taking a placebo.

Pancreatitis in Clinical Trials

Reports from clinical trials show varying numbers regarding pancreatitis. In pooled studies of oral semaglutide (the active ingredient in Ozempic tablets, also known as Rybelsus), 6 people reported pancreatitis compared to 1 in the comparator group. This suggests a potential, albeit small, increase in reported cases with oral semaglutide. However, a more recent meta-analysis, which included about 35,000 patients, found that semaglutide is not associated with a higher risk of pancreatitis compared to placebo. This conflicting data indicates that while pancreatitis can occur in patients taking Ozempic, it might not be directly caused by the medication in all instances, or the overall risk may not be elevated.

Symptoms and Duration

Pancreatitis is a potentially life-threatening condition that involves inflammation of the pancreas. It can lead to severe abdominal pain and digestive issues. The severe upper stomach pain may radiate to the back and can be accompanied by nausea or vomiting and a rapid heartbeat. Pancreatitis usually resolves within two weeks, but it can last longer. There was one report of chronic (long-term) pancreatitis in one patient taking Ozempic during clinical trials. This highlights that while most cases might be acute and resolve, there is a rare possibility of a chronic form developing. This underscores the importance of promptly recognizing symptoms.

Unclear Causation

Despite cases being reported, it remains unclear if Ozempic directly causes pancreatitis. The pancreas can become inflamed for various reasons, including gallstones, alcohol abuse, and high triglyceride levels. Therefore, when pancreatitis occurs in someone taking Ozempic, it can be challenging to definitively attribute it solely to the medication. However, because it has been reported, healthcare providers must be vigilant. Patients should be aware of the signs and symptoms. While more evidence is coming out showing no association between Ozempic and pancreatitis, there continue to be cases of people who are taking the medication reporting it. This ongoing reporting means that vigilance is necessary.

Monitoring and Patient Awareness

Patients taking Ozempic should be educated about the signs and symptoms of pancreatitis. If you experience severe upper stomach pain that radiates to your back, along with nausea, vomiting, or a rapid heartbeat, you should seek immediate medical attention. Early detection and treatment of pancreatitis are crucial for better outcomes. Even with meta-analyses suggesting no higher risk, the individual case reports mean that this remains a point of concern for some individuals. Potential complications of Ozempic include pancreatitis, and this serious condition warrants careful consideration and discussion between patients and their healthcare providers.

How does Ozempic affect vision?

Ozempic may affect vision, particularly by worsening an existing eye condition called diabetic retinopathy. This can happen as blood sugar levels improve rapidly, a common effect of the medication. Ozempic might also cause a condition called non-arteritic anterior ischemic optic neuropathy (NAION), which occurs when the optic nerve does not receive enough blood supply.

Worsening Diabetic Retinopathy

Diabetic retinopathy is a complication of diabetes that damages the blood vessels in the retina. When blood sugar levels drop too quickly, as can happen with effective diabetes medications like Ozempic, it can sometimes paradoxically lead to a temporary worsening of diabetic retinopathy. In a 2-year study, 3% of Ozempic injection users experienced complications related to diabetic retinopathy, compared to 1.8% of those taking a placebo. This difference suggests a potential link, especially for individuals already prone to this eye condition. In pooled placebo and active-controlled trials, 4.2% of oral semaglutide (Rybelsus/Ozempic tablet) users reported diabetic retinopathy compared to 3.8% in the comparator group. This indicates that the effect is not limited to the injectable form.

Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)

Another potential vision problem associated with Ozempic is non-arteritic anterior ischemic optic neuropathy (NAION). This condition involves a sudden, painless loss of vision in one eye due to insufficient blood flow to the optic nerve. While NAION is generally considered a rare condition, its potential link to medications like Ozempic means that any changes in vision should be reported to a healthcare provider promptly. The mechanism by which Ozempic might contribute to NAION is not fully understood, but it highlights the systemic effects that the medication can have beyond blood sugar regulation.

Importance of Eye Monitoring

For individuals with diabetes, especially those with pre-existing diabetic retinopathy, regular eye exams are critical when starting or continuing Ozempic. Rapid improvements in blood sugar control need to be carefully monitored by an ophthalmologist to detect and manage any worsening of retinopathy. Early detection allows for timely intervention, which can help preserve vision. Patients should be vigilant for any changes in their vision, including blurred vision, dark spots, or sudden vision loss, and report them immediately to their doctor. This proactive approach helps to mitigate potential long-term vision problems.

Comprehensive Patient Care

Our commitment to patient safety means emphasizing comprehensive care that includes monitoring for potential ocular side effects. While the benefits of Ozempic in managing blood sugar and weight are significant, these vision concerns underscore the importance of a holistic view of patient health. The data from the 2-year study, showing 3% of Ozempic injection users experiencing complications versus 1.8% on placebo, provides a tangible reason for this vigilance. Patients need to understand that managing diabetes and weight involves monitoring various aspects of their health, including their eyes. This integrated approach ensures that the overall health benefits outweigh potential risks, and that any adverse effects are addressed swiftly.

Is there a risk of thyroid tumors with Wegovy?

Wegovy may cause serious side effects, including the possibility of thyroid tumors, which could include cancer. This is a significant safety concern that patients and healthcare providers must be aware of before starting treatment.

Rodent Studies and Thyroid Tumors

In studies conducted with rodents, Wegovy and other medicines that work similarly to Wegovy were found to cause thyroid tumors, including thyroid cancer. These findings are a critical part of the safety information for Wegovy. It is important to note that animal studies do not always translate directly to humans. However, these results raise a red flag that necessitates careful consideration. The mechanism behind these tumors in rodents involves the GLP-1 receptor, which Wegovy targets. This observation leads to a cautious approach regarding human use.

Unknown Human Risk

Despite the findings in rodents, it is not currently known if Wegovy will cause thyroid tumors or a specific type of thyroid cancer called medullary thyroid carcinoma (MTC) in people. This uncertainty means that while a risk has been identified in animal models, the actual risk for humans is still under investigation. The absence of definitive human data means that healthcare providers must proceed with caution and inform patients about this potential risk. The lack of a clear answer for humans makes it a critical point of discussion for anyone considering Wegovy.

Contraindications for Use

Because of this potential risk, there are specific contraindications for using Wegovy. You should not use Wegovy if you or any of your family members have ever had medullary thyroid carcinoma (MTC). Additionally, if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), Wegovy is also not recommended. These are serious conditions that increase the baseline risk for thyroid cancer, and adding Wegovy could potentially exacerbate that risk. These contraindications are in place to protect patients who might be at a higher genetic or familial predisposition to thyroid issues.

Symptoms to Monitor

Patients taking Wegovy should be vigilant for symptoms that could indicate a thyroid tumor. These symptoms include getting a lump or swelling in your neck, experiencing hoarseness, having trouble swallowing, or feeling shortness of breath. If any of these symptoms appear, it is crucial to tell your healthcare provider immediately. These may be signs of thyroid cancer and require prompt medical evaluation. Early detection is vital for managing any potential thyroid issues. The Wegovy Important Safety Information clearly outlines these warnings, emphasizing the importance of patient awareness and reporting.

Ongoing Research and Patient Education

The ongoing assessment of Wegovy's long-term safety profile includes continued monitoring for thyroid-related issues in humans. Patient education is paramount so individuals can make informed decisions and be aware of what symptoms to look for. While Wegovy offers significant benefits for weight management, particularly in individuals with obesity, understanding and mitigating all potential risks is essential. The information from rodent studies serves as a crucial alert, guiding both prescribing practices and patient vigilance.

What other serious long-term effects are associated with Ozempic?

Beyond pancreatitis and vision problems, Ozempic has other rare but serious long-term side effects. These can include gallbladder problems, kidney issues, and gastrointestinal complications like stomach paralysis (gastroparesis) or intestinal blockage. Rapid weight loss from Ozempic can also lead to changes in body composition, sometimes referred to as “Ozempic face” or “Ozempic body.”

Gallbladder Disease and Complications

Gallbladder problems are among the rare but serious long-term effects associated with Ozempic. These can include gallstones, which are hardened deposits of digestive fluid that can form in your gallbladder. If these gallstones cause blockages or inflammation, it can lead to severe pain, nausea, and vomiting, potentially requiring surgery. The exact mechanism by which Ozempic might contribute to gallbladder issues is still being studied, but it is a recognized potential complication. Patients experiencing sudden, severe pain in the upper right abdomen should seek medical attention.

Kidney Damage and Function Loss

Ozempic has been associated with kidney damage and function loss in some individuals. While Ozempic may help protect heart and kidney health in people with type 2 diabetes or obesity, this benefit can be offset by potential risks in other contexts. Dehydration, often a consequence of severe gastrointestinal side effects like vomiting and diarrhea, can put significant strain on the kidneys. If not properly managed, this can lead to acute kidney injury or worsen existing kidney disease. Therefore, maintaining adequate hydration is crucial for patients taking Ozempic, particularly those experiencing digestive upset.

Stomach Paralysis (Gastroparesis) and Intestinal Blockage

Gastrointestinal complications, while generally mild and temporary, can sometimes manifest as more severe and long-lasting issues. Stomach paralysis, or gastroparesis, is a rare but serious condition where the stomach muscles work poorly or not at all, preventing food from emptying properly. This can lead to chronic nausea, vomiting, bloating, and early fullness. Similarly, intestinal blockage, another rare complication, can cause severe abdominal pain, inability to pass gas or stool, and vomiting. These conditions can be debilitating and may require medical intervention. While the exact incidence is low, they are significant concerns for long-term users.

Mental Health Effects

Mental health effects are also listed as potential long-term issues. While the research does not provide specific details on these effects, it is a category that warrants attention. Changes in physical health, chronic conditions, and the experience of side effects can all impact mental well-being. Any new or worsening mental health symptoms, such as anxiety or depression, should be discussed with a healthcare provider. A holistic approach to patient care includes monitoring both physical and mental health.

Protecting Heart and Kidney Health

Despite these potential long-term risks, it is also important to recognize that Ozempic may help protect heart and kidney health in people with type 2 diabetes or obesity. This protective effect is a significant benefit, especially for those with cardiovascular risk factors. The medication's ability to improve blood sugar control and promote weight loss can have positive downstream effects on these vital organs. Therefore, the decision to use Ozempic often involves balancing its known benefits against its potential, albeit rare, long-term risks. Comprehensive discussions with healthcare providers are essential to weigh these factors for each individual patient. Ozempic long-term side effects should be carefully evaluated in light of these benefits.

Frequently Asked Questions

Are Ozempic's side effects usually long-lasting?

Most of Ozempic's side effects are short-term and tend to improve over time or when the medication is stopped. Common issues like abdominal pain, nausea, and loss of appetite usually subside as your body adjusts. For many people, Ozempic side effects after 3 months improve significantly. However, there are rare instances where certain problems, such as pancreatitis, vision changes, or kidney issues, can become long-term concerns, potentially lasting months or years.

What are the most common gastrointestinal issues with Ozempic?

The most common gastrointestinal issues associated with Ozempic include nausea, vomiting, diarrhea, abdominal pain, and indigestion or heartburn. These symptoms are particularly prevalent when first starting the medication or after a dose increase. In pooled studies of oral semaglutide, 6 people reported pancreatitis compared to 1 in the comparator group, highlighting that while GI issues are common, serious ones like pancreatitis are rarer. These issues generally lessen as your body adapts to the medication.

Can Ozempic affect kidney health long-term?

Ozempic has the potential to affect kidney health long-term, although it can also offer protective benefits for kidneys in people with type 2 diabetes or obesity. Severe gastrointestinal side effects like vomiting and diarrhea can lead to dehydration, which can, in turn, cause acute kidney injury or worsen existing kidney conditions. Clinical trials studied Ozempic for 41 months in adults with type 2 diabetes and chronic kidney disease, indicating a focus on understanding these long-term kidney effects.

Is there a link between Ozempic and gallbladder disease?

Yes, there is a recognized link between Ozempic and gallbladder disease, although it is considered a rare but serious long-term side effect. This can include the formation of gallstones, which may lead to inflammation or blockages in the gallbladder. Patients experiencing symptoms such as sudden and severe pain in the upper right abdomen should seek medical attention promptly.

What should I do if I experience severe abdominal pain while on Ozempic?

If you experience severe upper stomach pain that may radiate to the back, accompanied by nausea, vomiting, or a rapid heartbeat while on Ozempic, you should seek immediate medical attention. These symptoms could indicate pancreatitis, a serious condition. In one 2-year study, 8 people taking injectable Ozempic experienced pancreatitis compared to 10 people taking a placebo, suggesting that while rare, it is a known concern that requires prompt evaluation.

Sources

  1. https://www.drugs.com/medical-answers/what-long-term-side-effects-ozempic-3578238/
  2. https://www.triallaw1.com/potential-complications-and-long-term-effects-of-ozempic/
  3. https://ro.co/weight-loss/long-term-side-effects-of-ozempic/
  4. https://www.wegovy.com/obesity/starting-wegovy/starting-wegovy-pen.html

Related Reading

— The The GLP-1 Daily Team

On Google

Get our answers in your Google results.

Add The GLP-1 Daily as a preferred source and Google will surface our reporting more often — in Top Stories and AI answers, marked with a preferred badge. One tap, free, undo anytime.

Add us as a preferred source

Opens Google's source preferences for theglp1daily.com. No sign-up with us — it's a Google setting.

Medication Finder

Which GLP-1 medication might work for you?

Related

Stay in the loop

Get the latest articles delivered to your inbox.